Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008 FORD, Mass., May 15 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), a leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, today announced the
Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008 FORD, Mass., May 15 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), a leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, today announced the
Insulet Corporation to Report First Quarter 2008 Financial Results on Tuesday, May 13, 2008 BEDFORD, Mass., April 23 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, announced plans to release
Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17 BEDFORD, Mass., Feb. 20 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin Management System, announced plans
Insulet Corporation to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 7, 2008 BEDFORD, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in wearable insulin pump technology with its OmniPod ® Insulin
Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008 BEDFORD, Mass., Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that
Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced plans to release its financial
Insulet Corporation Announces Pricing of Secondary Public Offering BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced the pricing of its public offering of 4,898,398 shares
Insulet Corporation Announces Proposed Secondary Public Offering of Common Stock BEDFORD, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced today that it has filed a registration statement
Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program BEDFORD, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the maker of the OmniPod ® Insulin Management System, today announced that it has been awarded a home medical
Insulet Corporation to Present at the William Blair Small Cap Growth Conference on October 3, 2007 BEDFORD, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that Duane DeSisto,